Clinical Laboratory in Ohio

DEM Medical (PADCO Holding Company) is a turnkey product development and contract manufacturing firm specializing in FDA-compliant, ISO 13485:16-certified medical device manufacturing. Founded in 1993 and based in the USA, DEM provides end-to-end design, engineering, and manufacturing services for the medical device industry, with capabilities spanning printed circuit board assemblies (PCBA), custom cabling and connectors, injection molding, 3D printing and rapid prototyping, and tooling design. The company is vertically integrated—all design, engineering, and production occur in-house—enabling rapid prototyping (as little as 10 weeks from concept to prototype), transparent pricing, and rigorous quality assurance. DEM holds ITAR, ISO 9001:15, ISO 13485:16, IPC-620, FDA Class II, REACH, and RoHS certifications. The firm serves medical device OEMs, startups, and innovators requiring custom, low-to-high-volume production with dependable delivery schedules and compliance-ready solutions.

DiaPharma Group, Inc. manufactures specialty research and clinical assay kits, reagents, and hemostasis analyzers for bleeding/clotting disorders, thrombosis, liver disease, drug-induced organ injury, and anti-cancer drug development. Founded in 1997, the company employs scientists with expertise in hemostasis, coagulation testing, platelet function analysis, fibrosis biomarkers, and NETosis research. DiaPharma offers chromogenic substrates, ADAMTS13 assays, Factor X testing, and mechanistic biomarkers for MASH, alcoholic liver disease (ALD), and drug-induced liver injury (DILI). The company provides personalized scientific support and customer service to clinical laboratories, research institutions, and pharmaceutical development teams.

Spot Health is a B2B platform provider specializing in at-home laboratory testing solutions for health brands, wellness companies, and telehealth platforms. The company operates a turnkey service that enables third-party brands to offer lab-analyzed blood, urine, and saliva tests with at-home sample collection under their own branding. Spot Health manages end-to-end logistics, including kit distribution, sample collection coordination, prepaid shipping to partner laboratories, and results integration into customer-facing applications. The platform handles regulatory compliance including state-level physician order requirements where applicable and maintains HIPAA compliance. Spot Health partners with established clinical laboratories for test analysis and provides medically-vetted result interpretations alongside normal ranges for seamless integration into client applications. The platform supports diverse use cases including personalized product recommendations (supplements, fitness programs, meal plans), chronic condition monitoring, cancer and STI screening, and efficacy studies for consumer health products. Key features include rapid deployment (launch in days rather than months), white-label customization to match client branding, and comprehensive documentation and API support for integration. Spot Health positions itself as infrastructure for the remote care and at-home diagnostics market, targeting health tech companies, telehealth platforms, and consumer wellness brands seeking to add laboratory testing capabilities without building proprietary lab operations.

YSI Incorporated is a manufacturer of water quality monitoring and laboratory analytical instruments headquartered in Yellow Springs, Ohio. The company designs and produces a comprehensive portfolio of portable handheld meters, multiparameter sondes, benchtop laboratory analyzers, autonomous monitoring systems, and data management platforms for environmental water quality assessment and process control applications. Primary product lines include the EXO sonde series for long-term unattended water monitoring, Pro Series portable handhelds (ProDSS, ProQuatro, ProSolo) for field sampling, MultiLab benchtop multiparameter instruments with wireless capabilities, and IQ SensorNet online monitoring systems. YSI also manufactures specialized instruments such as the 9200 Total Organic Carbon Analyzer, ColorVis optical spectrophotometer, THM 1000 VOC analyzer, and autonomous platforms including the SurfBee surface vehicle and EcoMapper Nano underwater vehicle. The company offers integrated solutions through the HydroRIG remote data logger and HydroSphere cloud-based data visualization platform. Markets served include environmental consulting, wastewater treatment, drinking water utilities, aquaculture, research institutions, and industrial process monitoring. YSI provides expert consultation services, on-demand training programs (EXO University), and product selection tools to assist customers in instrument choice and application design. The company is part of Xylem, a global water technology leader.

CNMC Company is a specialized supplier of radiation physics and quality assurance equipment serving the medical radiation community. The company provides a comprehensive portfolio of dosimetry devices, ionization chambers, survey meters, brachytherapy accessories, phantoms, and calibration services. CNMC specializes in products for linear accelerator QA/QC, diagnostic radiology, brachytherapy localization, IMRT planning, and radiation protection. The product range includes electrometers, diode and MOSFET dosimeters, TLD dosimeters, ion chamber survey meters, personal dosimeters, various ionization chamber types, positioning and immobilization devices, and custom QA phantoms. The company also offers repair services and unparalleled customer support with custom product development capabilities.

JETA Molecular BV is a molecular diagnostics company specializing in transplantation medicine, with particular focus on post-transplant monitoring solutions. The company develops and commercializes in vitro diagnostic (IVD) assays and software for early detection of transplant rejection and disease relapse following hematopoietic stem cell transplantation (HSCT) and solid organ transplantation. Core product lines include QTRACE® chimerism analysis systems utilizing quantitative PCR (qPCR) technology with 80 INDEL assays for recipient-derived white blood cell monitoring, DigitalTRACE™ digital PCR (dPCR) assays for sensitive chimerism detection, and HLA TRACE™ assays for detecting HLA loss of heterozygosity (LOH) post-HSCT. The company also offers TRACE Analysis™ software for qPCR data analysis, protocol generation, longitudinal sample tracking, and LIMS integration. JETA's solutions enable clinicians to adjust immunosuppression regimens, optimize graft survival, and improve patient outcomes. The company was founded by researchers with extensive expertise in IVD/CE-marked assay development, ASR/GPR designation, and RUO molecular diagnostic kits for transplantation and human genetic testing. JETA maintains collaborations with key opinion leaders in stem cell and solid organ transplantation. The company operates as a European entity based in Utrecht, The Netherlands, with product distribution through established diagnostic partners.